Could a drug combination prevent people with the eye disease uveitis lose their sight?

Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evaluate a drug combination treatment for the eye disease thanks to funding of £ 2.5 million by the National Institute for Health Research (NIHR). The study will be co-ordinated by the University's Bristol Trials Centre (CTEU).
Source: University of Bristol news - Category: Universities & Medical Training Tags: Grants and Awards, Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Translational Health Sciences; Press Release Source Type: news